PROmOting Gynecologic Cancer Patients With Frailty to Achieve Functional Recovery

Recruiting now

Conditions studied: Malignant Female Reproductive System Neoplasm, Gynecologic Cancer, Gynecologic Neoplasm

In brief

This study seeks to understand how frailty, a term that describes people who are more vulnerable stressors such as a new medical problem, affects the outcomes and quality of life in adult patients with gynecologic cancer.

Key facts

Study ID

NCT06089083

Run by

University of California, San Francisco

People needed

500

Starts

2023-10-18

Expected to finish

2033-11-30

Last updated by the study team

2026-01-26

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Age 18 years or greater
• Undergoing evaluation for a newly diagnosed gynecologic malignancy
• Ability of individual or legal guardian/representative to understand a written informed consent document, and the willingness to sign it

You may not qualify if…

• Contraindication to any study-related procedure or assessment
• Does not speak a language for which the consent form and study materials are available

Where it is running

• University of California, San Francisco — San Francisco, California, United States (enrolling)
• Dana Farber Cancer Institute — Boston, Massachusetts, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.